Articles tagged with: Stem Cell Transplant

Opinion»

[ by | Jun 11, 2014 3:26 pm | 16 Comments ]
Mohr’s Myeloma Musings: Pre-Game Nerves

During my 25-year career as a boy’s basketball head coach, I coached over 600 games.

Regardless of whether it was the 1983 Class A state championship game in my rookie year as a head coach (we lost), or games against opponents that we were overwhelming favorites to defeat, my state of mind the night before each one of those 600 plus games never changed.

That state of mind is difficult to describe. It was one of unbearable ex­cite­ment, tempered by an actual feeling of fear. Fear that I had not …

Read the full story »

Opinion»

[ by | Apr 17, 2014 11:58 am | 28 Comments ]
Mohr’s Myeloma Musings: Plant Your Feet And Stand Firm

Despite being a lifelong Boston Celtics fan, one of my favorite coaches is former Los Angeles Lakers coach Pat Riley.

I know that sounds traitorous to most Celtics fans, es­pe­cial­ly con­sider­ing the fierceness of the teams’ rivalry in the early and mid 1980s:  Bird versus Magic, Showtime versus Blue Collar, Kareem versus The Chief, McHale versus Worthy.

With all due respect to Lebron James, Kevin Durant, and the rest of the NBA today, those were the glory days of the NBA!

As a young coach during that time, I consumed …

Read the full story »

News»

[ by and | Mar 29, 2014 12:03 pm | 6 Comments ]
Large Study Sheds New Light On Tissue-Type Mismatches And Their Impact On Donor Stem Cell Transplant Outcomes

Significant improvements in donor stem cell trans­planta­tion have been made in recent years. As a result, donor trans­planta­tion – a procedure during which a patient receives stem cells from a healthy donor – has become safer and typically more successful for patients.

The majority of patients undergoing donor stem cell trans­planta­tion receive stem cells from unrelated donors. In these cases, a close match between donor and recipient tissue types is known to play an important important role in trans­plant outcomes.

A group of German researchers last fall published results of …

Read the full story »

News»

[ by and | Mar 13, 2014 6:34 am | 4 Comments ]
Patterns Of Post-Transplant Relapse And Progression Vary Among Multiple Myeloma Patients

A group of Spanish researchers published a summary last year of the patterns of re­lapse and progression they observed in multiple myeloma patients who underwent stem cell trans­plan­ta­tion as part of their upfront therapy.

The researchers observed re­lapse in over half of the patients included in the study.  Among these patients, the majority had only achieved a partial re­sponse after trans­plan­ta­tion.

They also found that how a patient re­lapsed had an impact on their prog­nosis after re­lapse.  Patients who re­lapsed based solely on changes in disease markers, such as their …

Read the full story »

News»

[ by | Dec 2, 2013 5:12 pm | 2 Comments ]
ASH 2013 Preview: Revlimid Maintenance Therapy For Multiple Myeloma

Results of several studies investigating Revlimid main­te­nance ther­a­py for mul­ti­ple myeloma will be presented at this year’s American Society of Hema­tol­ogy (ASH) annual meeting, which starts later this week.

Today’s article previews the results of the key Revlimid main­te­nance studies that will be presented at the meeting, drawing on findings pub­lished in the meeting abstracts.  Some of the study results, it should be noted, will be updated during the presentations at ASH this week and early next week.

The results to be presented at ASH are unlikely to settle the …

Read the full story »